Skip to content
Clinical Trials – home

Spitalul Clinic De Urgenta Pentru Copii Cluj-Napoca

Verified siteinfo

Romania Strada Crisan 3-5, 400177 Cluj Napoca, Romania

  • 9 trials recruiting
  • Juvenile idiopathic arthritis · Still's disease · Factor IX deficiency
  • Adults and children

About Specializations

Spitalul Clinic De Urgenta Pentru Copii Cluj-Napoca in Cluj Napoca, Romania specialises in clinical trials of conditions such as Juvenile idiopathic arthritis, Still's disease, Factor IX deficiency, Factor VIII deficiency, and other specialisations. This site conducts important research.

Main research areas of the site

Pediatric Nephrology

The medical center is at the forefront of pediatric nephrology, focusing on innovative treatments for children with kidney-related conditions. The ongoing research aims to address complex issues such as anemia associated with chronic kidney disease (CKD) in young patients.

  • Chronic Kidney Disease in Children
  • Anemia Management in Pediatric Patients
  • Pharmacokinetics and Pharmacodynamics in Pediatrics

By exploring the efficacy of novel therapies like roxadustat, the center contributes significantly to improving the quality of life for children suffering from CKD-related anemia.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Crisan 3-5400177 Cluj NapocaRomania
Recruiting now
9 trials
Conditions studied
12
Partner status
Verified site

More sites in Cluj NapocaRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

10 clinical trials

Schizophrenia

Recruiting

A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Esketamine
  • Sponsor:Janssen Cilag International

Pruritus

Recruiting

Study on the Safety of Difelikefalin for Adolescents with Itching Due to Chronic Kidney Disease on Hemodialysis

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Difelikefalin
  • Sponsor:Vifor Fresenius Medical Care Renal Pharma Ltd.

Still's disease+1

Recruiting

Study on the Effectiveness and Safety of Deucravacitinib for Children and Teens with Juvenile Psoriatic Arthritis

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Sarilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Equine immunoglobulin F(AB')2 fragments targeting shiga toxin
  • Sponsor:Chemo Research S.L.

Still's disease

Recruiting

Study of apremilast compared to placebo in children aged 5-17 years with juvenile psoriatic arthritis

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Apremilast
  • Sponsor:Amgen Inc.

Hyperkalaemia

Recruiting

Study on the Safety and Effectiveness of Sodium Zirconium Cyclosilicate for Children with High Potassium Levels

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Sodium Zirconium Cyclosilicate
  • Sponsor:AstraZeneca AB

Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Concizumab
  • Sponsor:Novo Nordisk A/S

Nephrogenic anaemia

Not yet recruiting

Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Darbepoetin Alfa
  • Sponsor:Astellas Pharma Global Development Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.